June 17, 2021
Nurosene is a Canadian healthtech company that aims to help users improve their mental health and overall brain performance. The firm describes itself as a “technology-driven wellness company.”
Nurosene was founded in May 2020 by CIO Daniel Gallucci, a trained functional neurologist. Around the same time, Nurosene raised $2.7 million in a funding round led by Stonecastle Investment Management and A2 Capital Management. Just over a year after launching, Toronto-based healthtech company Nurosene has gone public on the Canadian National Stock Exchange, raising $9.2 million CAD through its oversubscribed initial public offering.
Nurosene’s investors include NFL player and mental health advocate Richard Sherman, the company’s first brand ambassador. “I was really impressed with [Nurosene’s] vision and leadership and wanted to be a part of it,” Sherman told BetaKit.
With the IPO, Nurosene joins a number of other Canadian healthtech companies that have gone public in recent months, including Montréal telehealth firm Dialogue, Toronto-based virtual care and pharmacy company Mednow, and Toronto digital mental health firm MindBeacon, as they look to provide affordable, on-demand access to various types of healthcare.
Author: Chris Osei-Kusi